Cure8 research brief
Why This Matters
PRO2 and PRO3 were recorded far more often than CDAI or HBI in routine care and correlated strongly with those clinician-scored indices, so they may be a practical way to monitor Crohn’s activity and support real-world research.
Who Should Pay Attention
Clinicians and IBD care teams; researchers using EMR or registry data for IBD; adult patients with Crohn’s disease interested in disease monitoring.
Study Snapshot
What To Know
This study compared how often common Crohn’s disease activity scores could be calculated in routine care and how well simpler patient-reported outcome measures (PRO2 and PRO3) agree with longer clinician-scored indices (CDAI and HBI).
In a large Australasia electronic medical record dataset, PRO2/PRO3 were captured at about 81% of visits versus ~25–28% for CDAI/HBI. PRO2 and PRO3 showed strong correlation and high agreement with CDAI and HBI severity categories.
Keep In Mind
Summary is grounded in the article abstract (structured content depth: abstract). The study reports capture rates and correlations from an Australasia EMR; it does not provide patient-level outcomes or implementation guidance beyond the reported data.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.